Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Warnex Reports Revenues Of CAD4.7 Million In Q3 2009
“Our year-to-date revenues of CAD17.6 million are slightly below last year due to reduced volume in our Bioanalytical division. We have had an unprecedented number of cancellations and
“Our year-to-date revenues of CAD17.6 million are slightly below last year due to reduced volume in our Bioanalytical division. We have had an unprecedented number of cancellations and
Esperion Therapeutics has initiated a Phase I clinical study for ETC-1002, the company’s novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
UnitedHealth, Prescription Solutions and the National Council on Patient Information and Education (NCPIE) have released a new survey, which shows that 54% of Americans say they do not
Sanofi-aventis is due to announce the results of cross-sectional study of ‘SITE’ (Screening India’s Twin Epidemic). The objective of the study was to quantify and instill awareness amongst
“HairDX is a very valuable tool to determine early stages of Androgenetic Alopecia. Noninvasive treatment possibilities are greatly enhanced by early action on Androgenetic Alopecia,” says Dr. Carlos
Immuno Solid-phase Allergy Chip, or ISAC, is a multi-array technology package designed to provide a detailed assessment of specific allergies as part of the initial patient assessment and
Tokyo CRO and Ecron Acunova have formed a strategic alliance strengthening their services in India, Europe and Japan providing sponsors with a global network. The alliance will provide
Merck Eprova has signed an exclusive license agreement with Isofol Medical of Sweden to utilise Merck Eprova’s proprietary folate compound Modufolin in oncology. The use of Modufolin is
Novartis has launched Prevacid24HR (lansoprazole delayed-release capsules 15mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid24HR has received FDA approval in
Diamyd Medical has completed patient recruitment in European Phase III study of the diabetes vaccine Diamyd. It is estimated that results from the study can be reported during